Surebion, Inc. — Form D
Surebion, Inc. of LOS ANGELES, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-05. The offering totals $35, of which $35 was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-09-05
- Form: D
- Accession: 0002083970-25-000001
- Industry: Biotechnology
- Exemptions: 04, 06b
- Total offering: $35
- Amount sold: $35
- Minimum investment: $1
- Investors: 5
- Date of first sale: 2025-08-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-556723
Issuer
- Name: Surebion, Inc.
- CIK: 0002083970
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 7938 READING AVENUE, LOS ANGELES, CA, 90045
- Phone: 3109939664
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Troy Barring | Director | Santa Clarita, CA |
| Robert Damoiseaux | Director | Los Angeles, CA |
| Susanne Nichalas | Director | Los Angeles, CA |
| Troy Barring | Executive Officer | Santa Clarita, CA |
| Stephen Paul Rothman | Executive Officer | Mill Valley, CA |
More